fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Poster Session at ECC 2013 – Screening in colorectal cancer works

Written by | 29 Nov 2013

Discussion of the abstract by Professor Philippe Autier, Vice President, Population Studies, at the International Prevention Research Institute, Lyon, France.

ASCO 2013 – Although better defined, role of PSA in prostate cancer screening remains controversial

Written by | 26 Jun 2013

In recent years, there has been an adjustment in the scientific thinking about the utility of screening men for prostate cancer using prostate-specific antigen (PSA).

ASCO 2013 – Cancer services in the United Kingdom: Improving nicely

Written by | 25 Jun 2013

by Elizabeth C. Smyth, MB, BCh, MSc, and David Cunningham, MD, FRCP, FMedSci – In 2000, in order to optimise service provision for patients with cancer, 34 “Cancer… read more.

Short-term folic acid use does not appear to increase cancer risk

Written by | 15 Mar 2013

Taken from The Lancet – by Bruce Sylvester – Short-term folic acid supplement use does not affect overall cancer risk and does little to increase the risk of… read more.

ASCO GU Report 2013 – Anticoagulation benefits prostate cancer patients

Written by | 21 Feb 2013

by Ed Susman – Orlando, Florida – Researchers said they were surprised to find that prostate cancer patients treated with anticoagulants appear to achieve a longer median overall… read more.

Cancer mortality down 20 percent from 1991 peak

Written by | 20 Feb 2013

As of 2009, the overall death rate for cancer in the United States had declined 20 percent from its peak in 1991, translating to the avoidance of approximately… read more.

The factor that could influence future breast cancer treatment

Written by | 19 Feb 2013

Researchers have shown in the laboratory how a ‘transcription factor’ causes breast cancer cells to develop an aggressive subtype that lacks sensitivity to oestrogen and does not respond… read more.

Costly prostate cancer treatment offers little relief from side effects

Written by | 18 Feb 2013

Prostate cancer patients receiving the costly treatment known as proton radiotherapy experienced minimal relief from side effects such as incontinence and erectile dysfunction, compared to patients undergoing a… read more.

Prostate cancer study tracks long-term urinary, sexual and bowel function side effects

Written by | 18 Feb 2013

A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences… read more.

Change in PSA levels over time can help predict aggressive prostate cancer

Written by | 21 Jan 2013

Measurements taken over time of prostate specific antigen, the most commonly used screening test for prostate cancer in men, improve the accuracy of aggressive prostate cancer detection when… read more.

Targeted prostate biopsy has potential to improve diagnosis of prostate cancer

Written by | 21 Jan 2013

Magnetic resonance ultrasound fusion biopsy may aid in selection of patients for active surveillance versus aggressivetherapy, new study in The Journal of Urology® reports

PRT versus IMRT toxicity in prostate cancer

Written by | 21 Dec 2012

There is no difference between proton radiotherapy (PRT) and intensity-modulated radiotherapy (IMRT) when comparing the toxicity among  patients with prostate cancer at 12 months post-treatment according to a… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.